¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ¼ÒÇÁÆ®¿þ¾î Á¦°øº°, ¼ÒÇÁÆ®¿þ¾î À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Orthopedic Surgical Planning Software Market Size, Share & Trends Analysis Report By Software Delivery (Cloud Based, On Premise), By Software Type (Pre-Operative, Post Operative), By End-use, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå
:
1701289
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 150 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¹Ì±¹ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 3,487¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2030³â 6.05%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
È¿À²ÀûÀÎ ¿öÅ©ÇÃ·Î¿ì °ü¸®¸¦ À§ÇØ º´¿ø ¹× Ŭ¸®´Ð¿¡¼ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾îÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾÷°èÀÇ ±â¼ú ¹ßÀü°ú Á¤È®¼º ¹× È¿À²¼ºÀÇ Çõ½ÅÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 6¿ù Radlink, Inc.´Â °í°üÀý Àüġȯ¼ú ½Ã ÄÅÀÇ À§Ä¡¸¦ Æò°¡ÇÏ°í °ñ¹ÝÀÇ ±â¿ï±â¿Í ôÃß °ñ¹ÝÀÇ À̵¿¼ºÀ» ó¸®Çϵµ·Ï ¼³°èµÈ ¼ö¼ú Áß ¼ÒÇÁÆ®¿þ¾îÀÎ Radlink3D¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ±â¼úÀº ¼ö¼ú Àü °èȹ¿¡ 2D-3D µî·ÏÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù.
¼¼°è Àα¸ÀÇ °í·ÉÈ¿¡ µû¶ó °ñ°üÀý¿°, ÅðÇ༺ °üÀý Áúȯ, °ñÀý, °ñ´Ù°øÁõ µî ³ëÈ °ü·Ã Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·üÀÌ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, WHO º¸°í¼¿¡ µû¸£¸é 2030³â±îÁö Àü ¼¼°è Àα¸ 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ̶ó°í ÇÕ´Ï´Ù. ±× ¶§ 60¼¼ ÀÌ»ó Àα¸ÀÇ ºñÀ²Àº 2020³â 10¾ï ¸í¿¡¼ 14¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ̸ç, 2050³â¿¡´Â Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸°¡ µÎ ¹èÀÎ 21¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ °èÃþÀº ½Ã°£ÀÌ Áö³²¿¡ µû¶ó »À¿Í °üÀýÀÌ ÀÚ¿¬ÀûÀ¸·Î ÅðÈµÇ°í ¿îµ¿ ´É·Â°ú ±ÙÀ°·®ÀÌ °¨¼ÒÇϱ⠶§¹®¿¡ Á¤Çü¿Ü°úÀû Áúȯ¿¡ ƯÈ÷ Ãë¾àÇÕ´Ï´Ù. µû¶ó¼ ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¶ÇÇÑ, ÃÖ¼Òħ½À ¼ö¼úÀº ÀÛÀº Àý°³, ÀûÀº Á¶Á÷ ¿Ü»ó, ºü¸¥ ȸº¹ ½Ã°£ µîÀÇ ÀåÁ¡À¸·Î ÀÎÇØ Á¤Çü¿Ü°ú¿¡¼ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ÀϹÝÀûÀÎ ½Ã¼ú¿¡´Â °üÀý°æ ¼ö¼ú, ³»½Ã°æ ôÃß ¼ö¼ú, ÃÖ¼Ò Ä§½ÀÀû Àΰø°üÀý ġȯ¼ú µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº º¹ÀâÇϱ⠶§¹®¿¡ ¼ö¼ú Àü, ÈÄ ¼¼½ÉÇÑ °èȹÀÌ ÇÊ¿äÇÕ´Ï´Ù. Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î´Â »ó¼¼ÇÑ 3D ½Ã°¢È, ½Ç½Ã°£ ½Ã¹Ä·¹À̼Ç, Á¤È®ÇÑ ÃøÁ¤À» Á¦°øÇÔÀ¸·Î½á Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ¿Ü°ú Àǻ簡 º¹ÀâÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ È¿À²ÀûÀ¸·Î Ž»öÇÏ´Â µ¥ µµ¿òÀÌ µÇ¾î ½ÃÀå ¼ºÀå °¡¼ÓÈ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ½ÃÀå ±â¾÷µéÀº ±¹³» ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ´Ù¾çÇÑ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ¼±ÅÃÇϰí ÀÖÀ¸¸ç, ¸ÞµåÆ®·Î´ÐÀº ÀÌ ºÐ¾ßÀÇ Ã·´Ü ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Á¤Çü¿Ü°ú ¼ö¼ú¿¡ ¸Â°Ô Á¶Á¤µÈ »õ·Î¿î AI ±â¹Ý ¼ö¼ú Àü °èȹ µµ±¸¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ´Â ¼ö¼ú °èȹ ÇÁ·Î¼¼½º¿¡ ÀΰøÁö´ÉÀ» ÅëÇÕÇÏ¿© Á¤È®¼º°ú Ä¡·á °á°ú¸¦ Çâ»ó½ÃŰ´Â ±¤¹üÀ§ÇÑ Ãß¼¼¸¦ ¹Ý¿µÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, 2024³â 6¿ù, Zimmer BiometÀº ÇコÄÉ¾î ¼ÒÇÁÆ®¿þ¾î Á¦°ø¾÷ü¿Í Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ü°áÇÏ¿© Á¤Çü¿Ü°ú ¼ö¼úÀÇ Á¤È®¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ AI ±â¹Ý ¼ö¼ú Àü °èȹ µµ±¸¸¦ °³¹ßÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÆÄÆ®³Ê½ÊÀº ¼ö¼ú °èȹ ±â¼úÀÇ Çõ½Å°ú °È¿¡ ´ëÇÑ ¼±µµÀûÀÎ ±â¾÷ÀÇ ³ë·ÂÀ» °Á¶ÇÕ´Ï´Ù.
¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- ¼ÒÇÁÆ®¿þ¾î ¹èÆ÷¸¦ ±â¹ÝÀ¸·Î Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®Àº 2024³â °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ±â¼ú ¹ßÀü Áõ°¡¿Í ÀÇ·á ½Ã¼³¿¡¼ ÀÌ ¼ÒÇÁÆ®¿þ¾î¸¦ ¿î¿µÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·Çϱ⠶§¹®ÀÔ´Ï´Ù.
- ¼ÒÇÁÆ®¿þ¾î À¯Çüº°·Î´Â ¼ö¼ú Àü ºÐ¾ß°¡ 2024³â ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ´Â ¼ö¼ú Àü ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î »ç¿ë°ú °ü·ÃµÈ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³±â ¶§¹®ÀÔ´Ï´Ù.
- ÃÖÁ¾ ¿ëµµº°·Î´Â Á¤Çü¿Ü°ú Ŭ¸®´Ð¿¡¼ ¼ö¼úÀ» ¿øÇϴ ȯÀÚ°¡ Áõ°¡Çϰí, ¼¼°èÀûÀ¸·Î Á¤Çü¿Ü°ú Ŭ¸®´ÐÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¤Çü¿Ü°ú Ŭ¸®´ÐÀÌ 2024³â ¸ÅÃâ Á¡À¯À²¿¡¼ ¿ìÀ§¸¦ Á¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óÀ§ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ºÐ¼® Åø
- PorterÀÇ Five Forces ºÐ¼®
- PESTLE ºÐ¼®
- Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ¾÷°èÀÇ ÇöÀç ½ÃÀå µ¿Çâ
- »ç·Ê ¿¬±¸ ºÐ¼®
Á¦4Àå ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î Á¦°ø ÃßÁ¤¡¤µ¿Ç⠺м®
- Á¤ÀÇ¿Í ¹üÀ§
- ¼ÒÇÁÆ®¿þ¾î Á¦°ø ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå(¼ÒÇÁÆ®¿þ¾î Á¦°øº°, 2018-2030³â)
- Ŭ¶ó¿ìµå ±â¹Ý
- ¿ÂÇÁ·¹¹Ì½º
Á¦5Àå ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®
- Á¤ÀÇ¿Í ¹üÀ§
- ¼ÒÇÁÆ®¿þ¾î À¯Çüº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå(¼ÒÇÁÆ®¿þ¾î À¯Çüº°, 2018-2030³â)
- ¼ö¼úÀü
- ¼ö¼úÈÄ
Á¦6Àå ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- Á¤ÀÇ¿Í ¹üÀ§
- ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå(ÃÖÁ¾ ¿ëµµº°, 2018-2030³â)
- º´¿ø
- Á¤Çü¿Ü°ú Ŭ¸®´Ð
Á¦7Àå ¹Ì±¹ÀÇ Á¤Çü¿Ü°ú ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : °æÀï ±¸µµ
- Âü¿© ±â¾÷
- ±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®, 2024³â
- Àü·« ¸ÅÇÎ
- ±â¾÷ °³¿ä
- Stryker
- Radlink, Inc.
- Zimmer Biomet
- DePuy Synthes(Johnson & Johnson Medical Devices Companies)
- Enhatch Inc.
- Brainlab AG
- Corin Group.
- EOS imaging(ATEC Spine Inc.)
- Formus Labs Ltd
- mediCAD.
LSH
¿µ¹® ¸ñÂ÷
U.S. Orthopedic Surgical Planning Software Market Growth & Trends:
The U.S. orthopedic surgical planning software market size is expected to reach USD 34.87 million by 2030 and is expected to expand at a CAGR of 6.05% from 2025 to 2030, according to a new study by Grand View Research, Inc. Increasing adoption of orthopedic surgical planning software by hospitals and clinics for efficient workflow management is driving market growth. Moreover, technological advancements and innovations in precision and efficiency in the industry boost market growth. For instance, in June 2021, Radlink, Inc. introduced Radlink3D, an intraoperative software designed to assess cup positions and address pelvic tilt and spinopelvic mobility during total hip replacement surgeries. This innovative technology employs 2D-3D registration for preoperative planning.
As the global population ages, there is a substantial rise in the prevalence of age-related orthopedic conditions, such as osteoarthritis, degenerative joint diseases, fractures, and osteoporosis. As per the WHO report, by the year 2030, one in every six individuals globally will be 60 years or older. At that time, the percentage of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By the year 2050, the global population of those aged 60 years and above will be twice as large, reaching 2.1 billion. This demographic is particularly vulnerable to orthopedic conditions due to the natural degeneration of bones and joints over time, along with decreased mobility and muscle mass. Thus, such factors are anticipated to fuel market growth over the forecast period.
Furthermore, minimally invasive surgeries have gained attention in orthopedics for their benefits, including smaller incisions, less tissue trauma, and faster recovery times. Common procedures include arthroscopy, endoscopic spinal surgeries, and minimally invasive joint replacements. These techniques necessitate thorough preoperative and postoperative planning because of their complexity. Orthopedic surgical planning software plays a crucial role by providing detailed 3D visualizations, real-time simulations, and precise measurements. This technology helps surgeons navigate complex anatomical structures effectively, contributing to the accelerated growth of the market.
Furthermore, market players are opting for various strategic initiatives expected to boost the growth of the market in the country. Medtronic has launched new AI-driven preoperative planning tools tailored for orthopedic surgeries, responding to the increasing demand for advanced technologies in the field. This initiative reflects a broader trend of integrating artificial intelligence into surgical planning processes to enhance precision and outcomes. In addition, in June 2024, Zimmer Biomet formed a strategic partnership with a healthcare software provider to develop AI-powered preoperative planning tools aimed at improving precision in orthopedic surgeries. Such collaborations emphasize the commitment of major players to innovate and enhance surgical planning technologies.
U.S. Orthopedic Surgical Planning Software Market Report Highlights:
- Based on software delivery, the cloud-based segment held the largest revenue share in 2024, owing to rising technological advancements, and a shortage of skilled professionals to operate and manage this software in healthcare facilities.
- Based on software type, the pre-operative segment dominated the market with revenue share in 2024, due to growing awareness regarding the benefits associated with the use of pre-operative surgical planning software.
- Based on end use, the orthopedic clinics owing to patients' increasing preference for surgery in orthopedic clinics and the increasing number of orthopedic clinics globally.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Software Delivery outlook
- 2.2.2. Software Type outlook
- 2.2.3. End Use outlook
- 2.3. Competitive Insights
Chapter 3. Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. U.S. Orthopedic Surgical Planning Software Market - Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. U.S. Orthopedic Surgical Planning Software Market: Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTLE Analysis
- 3.4. Current Market Trends in Orthopedic Surgical Planning Software Industry
- 3.5. Case Study Analysis
Chapter 4. U.S. Orthopedic Surgical Planning Software Market: Software Delivery Estimates & Trend Analysis
- 4.1. Definition and Scope
- 4.2. Software Delivery Market Share Analysis, 2024 & 2030
- 4.3. Segment Dashboard
- 4.4. U.S. Orthopedic Surgical Planning Software Market, by Software Delivery, 2018 to 2030
- 4.5. Cloud-based
- 4.5.1. Cloud-based Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. On-premise
- 4.6.1. On-premise Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Orthopedic Surgical Planning Software Market: Software Type Estimates & Trend Analysis
- 5.1. Definition and Scope
- 5.2. Software Type Market Share Analysis, 2024 & 2030
- 5.3. Segment Dashboard
- 5.4. U.S. Orthopedic Surgical Planning Software Market, by Software Type, 2018 to 2030
- 5.5. Pre-Operative
- 5.5.1. Pre-Operative Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Post Operative
- 5.6.1. Post Operative Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Orthopedic Surgical Planning Software Market: End Use Estimates & Trend Analysis
- 6.1. Definition and Scope
- 6.2. End Use Market Share Analysis, 2024 & 2030
- 6.3. Segment Dashboard
- 6.4. U.S. Orthopedic Surgical Planning Software Market, by End Use, 2018 to 2030
- 6.5. Hospitals
- 6.5.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Orthopedic Clinics
- 6.6.1. Orthopedic Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Orthopedic Surgical Planning Software Market: Competitive Landscape
- 7.1. Participant's Categorization
- 7.2. Company Market Position Analysis, 2024
- 7.3. Strategy Mapping
- 7.4. Company Profiles
- 7.4.1. Stryker
- 7.4.1.1. Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. Radlink, Inc.
- 7.4.2.1. Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. Zimmer Biomet
- 7.4.3.1. Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. DePuy Synthes (Johnson & Johnson Medical Devices Companies)
- 7.4.4.1. Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. Enhatch Inc.
- 7.4.5.1. Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. Brainlab AG
- 7.4.6.1. Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. Corin Group.
- 7.4.7.1. Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. EOS imaging (ATEC Spine Inc.)
- 7.4.8.1. Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Strategic Initiatives
- 7.4.9. Formus Labs Ltd
- 7.4.9.1. Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Strategic Initiatives
- 7.4.10. mediCAD.
- 7.4.10.1. Overview
- 7.4.10.2. Financial Performance
- 7.4.10.3. Product Benchmarking
- 7.4.10.4. Strategic Initiatives
°ü·ÃÀÚ·á